These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6431102)

  • 41. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M; Martin GE; McClure DE; Baldwin JJ; Watling KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):275-80. PubMed ID: 6141532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists.
    Grol CJ; Jansen LJ; Rollema H
    J Med Chem; 1985 May; 28(5):679-83. PubMed ID: 4039369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of a potential dopaminergic prodrug moiety in several ring systems.
    Cannon JG; Furlano DC; Dushin RG; Chang YA; Baird SR; Soliman LN; Flynn JR; Long JP; Bhatnagar RK
    J Med Chem; 1986 Oct; 29(10):2016-20. PubMed ID: 3761320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors.
    Shippenberg TS
    Neurosci Lett; 1991 Jan; 121(1-2):136-8. PubMed ID: 1826942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
    J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y; Yamawaki S
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat.
    Batsche K; Ashby CR; Lee C; Schwartz J; Wang RY
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1029-39. PubMed ID: 7912274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.
    Piercey MF; Lum JT
    Eur J Pharmacol; 1990 Jul; 182(2):219-26. PubMed ID: 2397740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C; Vallgårda J; Nelson DL; Björk L; Yu H; Andén NE; Csöregh I; Arvidsson LE; Hacksell U
    J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
    Wikström H; Sanchez D; Lindberg P; Arvidsson LE; Hacksell U; Johansson A; Nilsson JL; Hjorth S; Carlsson A
    J Med Chem; 1982 Aug; 25(8):925-31. PubMed ID: 6811743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat.
    Nash JF; Meltzer HY
    J Pharmacol Exp Ther; 1989 Apr; 249(1):236-41. PubMed ID: 2565390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat.
    Ahlenius S; Salmi P
    Eur J Pharmacol; 1994 Aug; 260(2-3):177-81. PubMed ID: 7988642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
    Neumeyer JL; Froimowitz M; Baldessarini RJ; Campbell A; Gao YG
    J Recept Res; 1988; 8(1-4):83-96. PubMed ID: 3385694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.